Publication Date

2012

Abstract

The results of a pharmacoeconomic study of the cost-effectiveness of posaconazole versus fluconazole in preventing invasive fungal infections ( IFIs ) in patients with graft-versus-host disease ( GVHD ) are reported.

Document Type

Journal Article

Access Rights

ERA Access

Access may be restricted.

Share

COinS